The use of molecular graphics in structure-based drug design. by Emsley, P, Debreczeni, J

Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution. by Barr, A, Debreczeni, J, Eswaran, J, Knapp, S

Crystal structure of human protein tyrosine phosphatase 14 (PTPN14) at 1.65-A resolution. by Barr, A, Debreczeni, J, Eswaran, J, Knapp, S

The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1. by Eswaran, J, Debreczeni, J, Longman, E, Barr, A, Knapp, S

Structure and substrate specificity of the Pim-1 kinase by Bullock, A, Debreczeni, J, Amos, A, Knapp, S, Turk, B

Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation. by Bullock, A, Rodriguez, M, Debreczeni, J, Songyang, Z, Knapp, S

Structure and substrate specificity of the Pim-1 kinase. by Bullock, A, Debreczeni, J, Amos, A, Knapp, S, Turk, B

Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. by Bullock, A, Debreczeni, J, Edwards, A, Sundström, M, Knapp, S

Structural basis of inhibitor specificity of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM-1) kinase. by Bullock, A, Debreczeni, J, Fedorov, O, Nelson, A, Marsden, B, Knapp, S

Ruthenium half-sandwich complexes bound to protein kinase Pim-1 by Debreczeni, J, Bullock, A, Atilla, G, Williams, D, Bregman, H, Knapp, S, Meggers, E

Ruthenium half-sandwich complexes bound to protein kinase Pim-1. by Debreczeni, J, Bullock, A, Atilla, G, Williams, D, Bregman, H, Knapp, S, Meggers, E

The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. by Baumli, S, Lolli, G, Lowe, E, Troiani, S, Rusconi, L, Bullock, A, Debreczeni, J, Knapp, S, Johnson, L

The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. by Baumli, S, Lolli, G, Lowe, E, Troiani, S, Rusconi, L, Bullock, A, Debreczeni, J, Knapp, S, Johnson, L

Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs by Eswaran, J, Lee, W, Debreczeni, J, Filippakopoulos, P, Turnbull, A, Fedorov, O, Deacon, S, Peterson, J, Knapp, S

Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs. by Eswaran, J, Lee, W, Debreczeni, J, Filippakopoulos, P, Turnbull, A, Fedorov, O, Deacon, S, Peterson, JR, Knapp, S

Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor. by Bullock, A, Russo, S, Amos, A, Pagano, N, Bregman, H, Debreczeni, J, Lee, W, von Delft, F, Meggers, E, Knapp, S

Structure of the human protein kinase MPSK1 reveals an atypical activation loop architecture. by Eswaran, J, Bernad, A, Ligos, J, Guinea, B, Debreczeni, J, Sobott, F, Parker, SA, Najmanovich, R, Turk, B, Knapp, S

Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases. by Eswaran, J, von Kries, J, Marsden, B, Longman, E, Debreczeni, J, Ugochukwu, E, Turnbull, A, Lee, W, Knapp, S, Barr, A

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation by Bullock, A, Das, S, Debreczeni, J, Rellos, P, Fedorov, O, Niesen, F, Guo, K, Papagrigoriou, E, Amos, A, Cho, S, Turk, B, Ghosh, G, Knapp, S

Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. by Bullock, A, Das, S, Debreczeni, J, Rellos, P, Fedorov, O, Niesen, F, Guo, K, Papagrigoriou, E, Amos, A, Cho, S, Turk, B, Ghosh, G, Knapp, S